Publicacións en colaboración con investigadores/as de Complejo Hospitalario de Toledo (2)

2019

  1. Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years

    Leukemia and Lymphoma

2007

  1. (-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes

    Cellular and Molecular Life Sciences, Vol. 64, Núm. 19-20, pp. 2690-2701